These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. p53 is required for cisplatin-induced processing of the mitochondrial fusion protein L-Opa1 that is mediated by the mitochondrial metallopeptidase Oma1 in gynecologic cancers. Kong B; Wang Q; Fung E; Xue K; Tsang BK J Biol Chem; 2014 Sep; 289(39):27134-27145. PubMed ID: 25112877 [TBL] [Abstract][Full Text] [Related]
8. Membrane depolarization activates the mitochondrial protease OMA1 by stimulating self-cleavage. Zhang K; Li H; Song Z EMBO Rep; 2014 May; 15(5):576-85. PubMed ID: 24719224 [TBL] [Abstract][Full Text] [Related]
9. Regulation of OPA1 processing and mitochondrial fusion by m-AAA protease isoenzymes and OMA1. Ehses S; Raschke I; Mancuso G; Bernacchia A; Geimer S; Tondera D; Martinou JC; Westermann B; Rugarli EI; Langer T J Cell Biol; 2009 Dec; 187(7):1023-36. PubMed ID: 20038678 [TBL] [Abstract][Full Text] [Related]
10. Prohibitin levels regulate OMA1 activity and turnover in neurons. Anderson CJ; Kahl A; Fruitman H; Qian L; Zhou P; Manfredi G; Iadecola C Cell Death Differ; 2020 Jun; 27(6):1896-1906. PubMed ID: 31819158 [TBL] [Abstract][Full Text] [Related]
11. Inducible proteolytic inactivation of OPA1 mediated by the OMA1 protease in mammalian cells. Head B; Griparic L; Amiri M; Gandre-Babbe S; van der Bliek AM J Cell Biol; 2009 Dec; 187(7):959-66. PubMed ID: 20038677 [TBL] [Abstract][Full Text] [Related]
12. OMA1 mediates OPA1 proteolysis and mitochondrial fragmentation in experimental models of ischemic kidney injury. Xiao X; Hu Y; Quirós PM; Wei Q; López-Otín C; Dong Z Am J Physiol Renal Physiol; 2014 Jun; 306(11):F1318-26. PubMed ID: 24671334 [TBL] [Abstract][Full Text] [Related]
13. Differentiation inducing factor 3 mediates its anti-leukemic effect through ROS-dependent DRP1-mediated mitochondrial fission and induction of caspase-independent cell death. Dubois A; Ginet C; Furstoss N; Belaid A; Hamouda MA; El Manaa W; Cluzeau T; Marchetti S; Ricci JE; Jacquel A; Luciano F; Driowya M; Benhida R; Auberger P; Robert G Oncotarget; 2016 May; 7(18):26120-36. PubMed ID: 27027430 [TBL] [Abstract][Full Text] [Related]
14. Loss of OMA1 delays neurodegeneration by preventing stress-induced OPA1 processing in mitochondria. Korwitz A; Merkwirth C; Richter-Dennerlein R; Tröder SE; Sprenger HG; Quirós PM; López-Otín C; Rugarli EI; Langer T J Cell Biol; 2016 Jan; 212(2):157-66. PubMed ID: 26783299 [TBL] [Abstract][Full Text] [Related]
15. Control of Mitochondrial Remodeling by the ATPase Inhibitory Factor 1 Unveils a Pro-survival Relay via OPA1. Faccenda D; Nakamura J; Gorini G; Dhoot GK; Piacentini M; Yoshida M; Campanella M Cell Rep; 2017 Feb; 18(8):1869-1883. PubMed ID: 28228254 [TBL] [Abstract][Full Text] [Related]
16. Mitochondrial function: OMA1 and OPA1, the grandmasters of mitochondrial health. McBride H; Soubannier V Curr Biol; 2010 Mar; 20(6):R274-6. PubMed ID: 20334834 [No Abstract] [Full Text] [Related]
17. p32/C1QBP regulates OMA1-dependent proteolytic processing of OPA1 to maintain mitochondrial connectivity related to mitochondrial dysfunction and apoptosis. Noh S; Phorl S; Naskar R; Oeum K; Seo Y; Kim E; Kweon HS; Lee JY Sci Rep; 2020 Jun; 10(1):10618. PubMed ID: 32606429 [TBL] [Abstract][Full Text] [Related]
19. Distinct effects of TRAIL on the mitochondrial network in human cancer cells and normal cells: role of plasma membrane depolarization. Suzuki-Karasaki Y; Fujiwara K; Saito K; Suzuki-Karasaki M; Ochiai T; Soma M Oncotarget; 2015 Aug; 6(25):21572-88. PubMed ID: 26057632 [TBL] [Abstract][Full Text] [Related]